Personal genome sequencing may be the next great technology frontier in public health—but how do patients feel about knowing, sharing and acting on their genetic information?
That’s a question researchers are exploring as more health-care providers, companies and research groups begin providing results of personal genome sequencing to patients and their doctors.
Unlike gene tests intended to identify the cause of a suspected or diagnosed genetic disease, a growing number of projects known as predispositional personal genome sequencing, or PPGS, aim to identify risks such as heart disease and cancer and provide other potentially useful personal information to ostensibly healthy people, according to a review published in May in the Journal of Personalized Medicine.
Read Full Article »